What is the recommended luteal phase support regimen—including progesterone type, dose, route, timing, and monitoring—for a woman undergoing assisted reproductive techniques or with luteal‑phase deficiency?

Luteal Phase Support in Assisted Reproductive Technology

For women undergoing ART, progesterone-based luteal phase support is essential and should be initiated between the evening of oocyte retrieval and day 3 post-retrieval, continuing until at least 8-12 weeks of gestation. The specific regimen depends on the type of ART cycle and individual patient characteristics.

Fresh IVF/ICSI Cycles

Standard Approach

Vaginal progesterone is the first-line choice for luteal phase support in fresh cycles 1. The evidence supports:

• Vaginal progesterone 90 mg gel daily OR 200 mg suppositories daily starting the evening of oocyte retrieval or within 3 days post-retrieval 2, 1
• Continue until at least positive pregnancy test, preferably through 8-12 weeks gestation 2, 3
• Intramuscular progesterone (250 mg weekly) shows similar efficacy but with less favorable tolerability 1

Route Comparison

Multiple routes are equally effective 2, 1:

• Vaginal: Most commonly used (90.9% of Italian centers), well-tolerated 3
• Intramuscular: Equivalent efficacy but requires injections
• Subcutaneous: Non-inferior to vaginal in good-prognosis patients 4
• Oral dydrogesterone: Emerging option requiring more validation 2

The vaginal route is preferred due to direct uterine delivery, avoiding first-pass hepatic metabolism, and superior patient acceptance 1.

Frozen Embryo Transfer (FET) Cycles

Hormone Replacement Therapy (HRT) Protocols

In artificial cycles without a corpus luteum, progesterone requirements are absolute:

• Vaginal progesterone 200 mg suppositories 2-3 times daily OR 90 mg gel daily 5, 2
• Some centers use higher doses in FET compared to fresh cycles 3
• Subcutaneous progesterone shows mixed results in FET, with increased miscarriage rates in oocyte donor recipients 4

Rescue Protocols for Low Serum Progesterone

When serum progesterone is <9-10 ng/mL on the day before embryo transfer, rescue luteal support improves outcomes 5, 6:

• Double the vaginal progesterone dose (e.g., from 200 mg to 400 mg daily) 5
• Add subcutaneous progesterone 25 mg daily if already on vaginal progesterone 5
• Intramuscular progesterone supplementation is frequently ranked highest for rescue 6

This individualized approach allows patients with initially low progesterone to achieve pregnancy rates comparable to those with adequate levels 5, 6.

Special Populations

Women with Prior Spontaneous Preterm Birth

This population requires 17-alpha hydroxyprogesterone caproate (17-OHP-C), NOT standard luteal support progesterone 7, 8:

• 17-OHP-C 250 mg intramuscularly weekly from 16-20 weeks until 36 weeks 8
• This reduces preterm birth <37 weeks by 34% 7
• If cervical length shortens to <25 mm despite 17-OHP-C, consider cerclage but continue 17-OHP-C 8

For women without prior preterm birth but with short cervix (≤20 mm at 18-24 weeks): vaginal progesterone 90 mg gel or 200 mg suppository daily 8

Multiple Gestations

Progesterone supplementation shows no benefit in twin or triplet pregnancies 8. Do not use progestogens for preterm birth prevention in multiples.

Adjunctive Therapies

hCG vs Progesterone Alone

• hCG increases OHSS risk without improving pregnancy outcomes 1
• Progesterone alone is preferred over hCG-based regimens 1

GnRH Agonist Addition

Adding GnRH agonist to progesterone improves outcomes 1:

• Live birth/ongoing pregnancy rates increase (OR 0.62 favoring progesterone + GnRHa, meaning GnRHa addition reduces the odds of NOT achieving pregnancy) 1
• Consider in high-responder patients or those at OHSS risk 9

Estrogen Addition

Adding estrogen to progesterone does NOT improve outcomes 1. There is no evidence supporting estrogen supplementation beyond standard progesterone 8.

Monitoring and Duration

Serum Progesterone Monitoring

• Check serum progesterone the day before embryo transfer in HRT-FET cycles 5, 6
• Target level: ≥9-10 ng/mL 5, 6
• If below threshold, implement rescue protocol immediately 5, 6

Duration of Support

Continue luteal support until 8-12 weeks gestation 2, 3:

• 80% of Italian centers continue through weeks 8-12 3
• Minimum duration: until positive pregnancy test 2
• Rationale: Corpus luteum remains primary progesterone source until placental takeover at 7-9 weeks

Common Pitfalls to Avoid

1. Do NOT use progesterone for preterm birth prevention in active preterm labor or PPROM 8 - insufficient evidence of benefit

2. Do NOT base embryo transfer decisions on endometrial characteristics 10 - endometrial thickness should not determine single vs. double embryo transfer

3. Do NOT use oral progesterone as first-line in fresh cycles - vaginal route has stronger evidence 1

4. Do NOT continue inadequate dosing when progesterone levels are low - implement rescue protocols promptly 5, 6

5. Do NOT confuse luteal phase support (for ART) with preterm birth prevention - these are distinct clinical scenarios requiring different progesterone formulations and dosing 7

Practical Algorithm

For Fresh IVF/ICSI:

• Start vaginal progesterone 90-200 mg daily evening of retrieval → Continue through 8-12 weeks

For HRT-FET:

• Start vaginal progesterone 200 mg 2-3x daily → Check serum level day before transfer → If <10 ng/mL: double dose or add subcutaneous → Continue through 8-12 weeks

For Prior Preterm Birth (NOT ART luteal support):

• 17-OHP-C 250 mg IM weekly from 16-20 weeks → Continue until 36 weeks → Monitor cervical length → If <25 mm: add cerclage, continue 17-OHP-C